The world is facing a monkeypox outbreak, and healthcare experts and public health officials are working hard. They aim to keep communities safe and healthy. A key part of this is using effective monkeypox vaccination strategies. This article will cover the vaccination recommendations, who can get it, and important things to think about. It will give you the info you need to understand this public health issue.
Key Takeaways
- Two doses of the JYNNEOS vaccine are recommended to provide stronger protection against monkeypox, with the second dose given 4 weeks after the first.
- Monkeypox vaccines may be available at health departments, public health clinics, hospitals, pharmacies, and large social gatherings or venues in some major cities, but accessibility can vary by location.
- The JYNNEOS vaccine is the primary vaccine used in the U.S. during the current monkeypox outbreak, with an intradermal administration option for high-risk individuals.
- Vaccination can result in side effects such as pain, redness, itching, and swelling at the injection site, as well as fever, headache, and muscle aches.
- It takes about 14 days after the second dose for the body to develop a strong immune response against monkeypox.
Monkeypox Vaccination: An Overview
The recent monkeypox outbreak has made vaccination a key topic. Monkeypox is caused by a virus similar to the one that causes smallpox. While there’s no cure, vaccines can help prevent it.
The FDA has approved two vaccines, Jynneos and ACAM2000, against monkeypox. These vaccines work best if taken before or right after getting the virus. The CDC has guides on how to use these vaccines, including an ID method for Jynneos.
It’s important to know about monkeypox vaccination, background, and immunization to make smart choices. This helps protect individuals and communities.
| Vaccine | Manufacturer | Dose Schedule | Route of Administration |
|---|---|---|---|
| Jynneos | Bavarian Nordic | 2-dose series, 4 weeks apart | Subcutaneous or Intradermal |
| ACAM2000 | Emergent BioSolutions | Single dose | Percutaneous |
As monkeypox cases grow, knowing about vaccines, who can get them, and possible side effects is key. Understanding monkeypox vaccination helps people make good choices. This can help stop the disease from spreading.
Monkeypox Vaccine Eligibility
The monkeypox outbreak in the United States is growing. The JYNNEOS vaccine is key to stopping the virus. The Centers for Disease Control and Prevention has set clear rules for who can get the vaccine.
Groups at High Risk for Monkeypox
The CDC suggests the monkeypox vaccine for those exposed to the virus or at high risk of getting it. This includes people who’ve been close to someone with monkeypox in the past two weeks. It also covers those with many sexual partners in areas where monkeypox is spreading. Healthcare workers and those handling samples or animals with similar viruses are also eligible.
Criteria for Vaccination Prioritization
Who gets vaccinated first depends on their risk and past exposure. The JYNNEOS vaccine is given under the skin twice, 28 days apart, for best protection. Those who complete the two doses are fully protected against monkeypox, with no need for boosters. The vaccine is also for people living in certain areas, like university students who haven’t had monkeypox before.
The CDC doesn’t advise vaccination for everyone yet. But the vaccine is free, with some places charging a small fee. It can be given in two ways, both needing two doses 28 days apart for full protection.
Jynneos: The Primary Monkeypox Vaccine
Jynneos, also known as Imvamune or Imvanex, is the main vaccine approved by the FDA. It helps prevent monkeypox in adults at high risk. You need two doses, given four weeks apart, for the best protection.
How Jynneos Vaccine is Administered
The Jynneos vaccine can be given in two ways. It can be injected into the fat layer under the skin or between skin layers. This second method is for people 18 and older at high risk. It uses less vaccine per dose, making more doses available.
Intradermal vs Subcutaneous Injection
Most people get the Jynneos vaccine under the skin. But, for some, it’s given between skin layers. This method is for those 18 and older at high risk. It uses less vaccine, helping stretch the limited supply. Both ways are safe and work well against monkeypox.
The Jynneos vaccine is a key tool against monkeypox. It’s safe and effective, especially with two doses. Jynneos is vital in controlling the spread of this disease.
ACAM2000: An Alternative Monkeypox Vaccine
JYNNEOS is the main vaccine approved for monkeypox. But, ACAM2000 is another choice made to fight smallpox. It uses a live virus that can spread. People get it through a skin prick, causing a small lesion or a red, itchy bump that heals over time.
But, ACAM2000 isn’t for everyone. It can have serious side effects, especially for those with weak immune systems, skin issues, or heart problems. The ACAM2000 monkeypox vaccine might lead to heart inflammation or brain issues, which could be deadly.
The alternative monkeypox vaccine, ACAM2000, is given in special cases with the person’s okay. Doctors must weigh the risks and benefits before giving it. The vaccine’s side effects can be severe, putting some people’s health at risk.
« ACAM2000 is not recommended for everyone, as it can cause serious side effects, particularly in individuals with weakened immune systems, certain skin conditions, or heart disease. »
| Vaccine | Administration | Potential Side Effects |
|---|---|---|
| ACAM2000 | Prick on the skin, leaving a small lesion or red, itchy bump | Myopericarditis, neurological events, ocular vaccinia, and other serious complications |
| JYNNEOS | Two-dose subcutaneous or intradermal injection | Local adverse events, but fewer severe side effects compared to ACAM2000 |
In summary, ACAM2000 is an option for monkeypox vaccine but not for everyone. It has serious side effects. Doctors must think carefully before using it for people at high risk of getting monkeypox.
monkeypox vaccination recommendations
The CDC has given out vaccination advice for monkeypox. This includes both post-exposure prophylaxis (PEP) and pre-exposure prophylaxis (PrEP). These methods aim to stop the virus from spreading and protect those at high risk.
Post-Exposure Prophylaxis (PEP)
PEP means getting a monkeypox vaccine within four days of being exposed to the virus. It can stop the virus from spreading and might prevent an infection. PEP is suggested for people who have been close to someone with monkeypox.
Pre-Exposure Prophylaxis (PrEP)
PrEP is for people at high risk of getting monkeypox. This includes lab workers, healthcare staff, and those in areas where monkeypox is common. The vaccine can protect you before you might be exposed, lowering the chance of getting infected.
The advice on monkeypox vaccines highlights the need for both PEP and PrEP. These strategies help control the outbreak and protect those most at risk. By using these methods, healthcare workers and health officials aim to slow down monkeypox and keep vulnerable groups safe.
Vaccine Side Effects and Precautions
The monkeypox outbreak has made it important to know about vaccine side effects and precautions. There are two main vaccines: Jynneos and ACAM2000. Each has its own set of things to consider.
Common Side Effects of Jynneos
The Jynneos vaccine is usually well-liked. It often causes pain, redness, and itching where you got the shot. You might also feel fever, headache, tiredness, nausea, chills, and muscle aches.
When given under the skin, Jynneos can cause more skin issues. These include itching, swelling, redness, and changes in skin color.
Potential Side Effects of ACAM2000
The ACAM2000 vaccine might cause more serious side effects. These can be fever, rash, swollen lymph nodes, and heart problems like myocarditis and pericarditis. People with weak immune systems or certain skin issues might be more likely to have these issues.
Before getting a monkeypox vaccine, it’s key to talk to your doctor about the side effects of Jynneos and ACAM2000. Knowing the risks and benefits helps you choose the best vaccine for your health needs.
Vaccine Availability and Distribution
The monkeypox outbreak has made getting vaccines a big concern. The U.S. government is working hard to increase the vaccine supply. They’re using the Strategic National Stockpile (SNS), a network of places that keep a huge amount of medical supplies.
The U.S. Department of Health and Human Services’ Administration for Strategic Preparedness and Response (ASPR) is leading these efforts. They’ve given out over 1 million free JYNNEOS vaccine vials. ASPR also ordered 5.5 million more vials, bringing the total to around 7 million by mid-2023.
Strategic National Stockpile (SNS)
The Strategic National Stockpile is key in getting monkeypox vaccines out. It sends vaccines to local health agencies during outbreaks or emergencies. This system makes sure vaccines get to where they’re needed most.
After the FDA gave the green light, healthcare providers can now use one JYNNEOS vial for up to five people. This makes the vaccine go further, helping more people get protected.
As the monkeypox situation changes, getting vaccines to people is a top goal. The Strategic National Stockpile and efforts to make more vaccines are key. They help make sure everyone can get the vaccine they need.
Vaccination Strategies and Prioritization
As the monkeypox outbreak grows, vaccination strategies are key to slowing its spread. There are two main ways to get vaccinated: post-exposure prophylaxis (PEP) and pre-exposure prophylaxis (PrEP).
PEP gives you a vaccine within 4 days of being exposed to the virus. It can prevent or lessen the illness’s severity. PrEP is for those at high risk, like lab workers and healthcare staff. It helps protect them before they might be exposed.
Who gets vaccinated first depends on their risk and past exposure. The Advisory Committee on Immunization Practices (ACIP) suggests vaccination for those exposed to monkeypox.
The Biden-Harris Administration is working fast to get the JYNNEOS vaccine to those who need it most. So far, the U.S. Department of Health and Human Services (HHS) has given out 296,000 doses. There are 56,000 ready now, and 240,000 more coming soon.
Also, over the summer, more than 750,000 JYNNEOS doses will be added. After inspection and release, another 500,000 doses will be available. This means a total of 1.6 million doses will be available this year.
So far, over 931,155 JYNNEOS vaccine doses have been given in the U.S. But, we need to make sure everyone has a fair chance to get vaccinated. The numbers show that Black and Hispanic people are getting vaccinated less than their share of the population.
Vaccine Efficacy and Protection
The monkeypox outbreak is growing, making it key to know how well vaccines work. Studies show the Jynneos vaccine, or MVA-BN, is very good at preventing monkeypox.
Immune Response Timeline
Getting two doses of the Jynneos vaccine is best for protection. After the second dose, your immune system peaks in two weeks. This gives you strong and lasting immunity.
Duration of Protection
The Jynneos vaccine is very effective, but how long it lasts is still being studied. The Centers for Disease Control and Prevention (CDC) is looking into this. They want to know how well the vaccine works now and how long it protects you.
| Vaccine Efficacy | One Dose | Two Doses |
|---|---|---|
| Estimated Effectiveness | 73.6% | 81.8% |
| Reported Variations | 35.8% to 86.4% | 66% to 89.5% |
Data shows the Jynneos vaccine gives strong protection against monkeypox. Two doses give the best immunity. But, we’re still learning about how long this protection lasts. More research will give us answers soon.
Monkeypox Transmission and Prevention
Monkeypox, also known as mpox, is a viral disease that spreads through close contact with an infected person or animal. Vaccination is now a key way to prevent it, along with isolation, tracing contacts, and avoiding close contact with the infected.
Mpox spreads mainly through direct contact with infected people or objects. It can also move from animals to humans. Symptoms include fever, sore throat, and a rash that can last 2-4 weeks.
To stop mpox from spreading, the CDC suggests targeted vaccination. Primary vaccination is for those at high risk, like gay or bisexual men with many partners. Post-exposure vaccination is for people who have been in contact with someone with mpox, ideally within four days.
Deciding to get vaccinated depends on the risks and benefits for each person. Mass vaccination isn’t needed or advised for mpox right now. Instead, we focus on vaccinating those most at risk. Keeping track of contacts and monitoring the situation are key to preventing mpox.
- Mpox is caused by the monkeypox virus, classified into two clades: clade I and clade II.
- The 2022–2023 global outbreak was due to a clade IIb strain.
- Mpox can be very serious for people like children, pregnant women, and those with weak immune systems.
Studying vaccine effectiveness is important for mpox prevention. By focusing vaccination efforts and other preventive steps, we can manage the outbreak and reduce future risks.
Vaccination for Special Populations
As the monkeypox outbreak grows, it’s key to make sure vulnerable groups get the vaccine. This includes kids and teens, and people with weak immune systems.
Children and Adolescents
The Jynneos vaccine is okay for kids under 18 at high risk of getting monkeypox. But, they need it through a subcutaneous injection, not the intradermal way for adults. Doctors should check with the New York State Department of Health (NYSDOH) for how to give it to kids and teens.
Immunocompromised Individuals
People with weak immune systems, like those with HIV, can also get the Jynneos vaccine. It’s safe for them, giving them an important shield against monkeypox.
As monkeypox spreads, making sure these groups get vaccinated is key. It’s about giving everyone a fair chance to stay safe.
Conclusion
The monkeypox vaccination overview shows how important vaccines are in fighting the outbreak. Vaccines like Jynneos and ACAM2000 have different ways to be given and can cause different side effects. Healthcare workers and people getting vaccinated need to think about these things carefully.
Those most at risk, like gay men with many partners, healthcare workers, and lab workers, are getting vaccinated first. Getting vaccinated before or after exposure can greatly lower the chance of getting monkeypox. This helps stop the virus from spreading.
Even though fully vaccinated people might get a milder case and spread the virus less, the key takeaways on monkeypox vaccination remind us to stay alert. Following health advice and watching the situation closely is key. As monkeypox continues to spread, we need ongoing research, monitoring, and updates on vaccines to fight it effectively.